Shampa Saha

Shampa Saha

Auto-generated profile, based on publicly available information

Shampa Saha

Dhaka 1207 Child Health Research Foundation

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in Vaccine
Verified
Journal Article
Open access
RMRoly Malaker
Roly Malaker
HAHasanuzzaman
Hasanuzzaman
YHYogesh Hooda
Yogesh Hooda
HRHafizur Rahman
Hafizur Rahman
RDRajib Chandra Das
Rajib Chandra Das
SSSamir K. Saha
Samir K. Saha
The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in March 2015 in Bangladesh. In this study, we aimed to estimate the impact of PCV10 on invasive pneumococcal disease (IPD) identified by blood cultures and severe pneumonia identified clinically and its effectiveness on invasive disease caused by vaccine serotypes. We conducted population-based surveillance among children aged 2- <24 months between April 2012 through March 2019 in Mirzapur, a rural sub-district of Bangladesh. We compared incidence of IPD and severe pneumonia before (April 2012 to March 2015) and after (April 2015 to March 2019) the introduction of PCV10. Vaccine effectiveness was measured using an indirect cohort analysis of data from four sentinel sites in which PCV10 vaccination status was compared between children with IPD caused by vaccine serotype vs. non-vaccine serotypes. We identified 24 IPD cases by blood culture and 1,704 severe pneumonia hospitalizations during the surveillance period. IPD incidence in under-2-year-old children fell 25 % (95 % CI: -1.2 % to 76 %; p-value = 0.59) from 106 cases per 100,000 child-years at baseline to 79.3 in April 2018- March 2019. Vaccine serotype-IPD incidence was lower (77 % reduction, 95 % CI: -0.45 % to 96 %; p-value = 0.068) in April 2018 - March 2019 than in the pre-vaccine period (85.7 cases to 19.8/100,000 child-years). A significant decline of 54.0 % (95 % CI: 47.0 % to 59.0 %; p-value < 0.001) was observed in hospitalizations due to severe pneumonia. From indirect cohort analysis, the effectiveness of PCV10 against vaccine serotype IPD was 37 % (95 % CI: -141.0 % to 83.5 %; p = 0.5) after the 1st dose and 63.1 % (95 % CI: -3.3 % to 85.9 %, p = 0.0411) after the 2nd or the 3rd dose. This study demonstrates that PCV10 introduction prevented hospitalizations with severe pneumonia and provided individual protection against vaccine serotypes.

16 September 2022
Verified
Journal Article
Open access
HSHeinz-Josef Schmitt
Heinz-Josef Schmitt
YSYauba Saidu
Yauba Saidu
KHKhrystyna Hrynkevych
Khrystyna Hrynkevych
AAAhmed M. Adam
Ahmed M. Adam
CACollins Ankunda
Collins Ankunda
MSMelvin Sanicas
Melvin Sanicas
Despite the huge benefits of vaccination, vaccine uptake around the globe is surprisingly suboptimal in most places; explanations include vaccine hesitancy and increasingly well-organized anti-vaccine groups. In addition, WHO identified structural gaps in many countries for the delivery of vaccination services, specifically a lack of scientifically sound NITAGs of the highest integrity, as well as a lack of political will and implementation. Here country vaccination systems were evaluated using simple 4×2 managerial criteria (having goals, one plan, implementation, and evaluation), to look into the structural ability of selected countries to deliver appropriate vaccination services, expressed as the Country Vaccination Score (CVS). Based on the availability of expert vaccinologists, each selected country was described (basic demographic, economic, political, health care data) followed by CVS-scoring. All data were centrally reviewed and validated. To date, a total of 42 countries received a CVS, with scores between 1 and 8. Some Low- and Middle-Income Countries (LMICs) scored high, whereas some high income countries scored low. The strengths of the system include the crowdsourcing approach, and scoring based on written documentation followed by a strict central review process. The main weakness may be that “what is on paper may not be what happens in reality”, i.e., overscoring may have happened. The ongoing project may help countries identifying structural gaps in delivering optimal vaccination services and take appropriate actions. Readers are invited to contribute with comments, additional data as well as by evaluating any of the more than 150 countries still missing.

29 April 2025 in VeriXiv
Verified
Preprint
Open access
ATArif Mohammad Tanmoy
Arif Mohammad Tanmoy
EKEsha Kazi
Esha Kazi
NKNaito Kanon
Naito Kanon
MRMd Hafizur Rahman
Md Hafizur Rahman
HHHarry C H Hung
Harry C H Hung
SSSenjuti Saha
Senjuti Saha

28 February 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
BMB. Mishra
B. Mishra
PPP. Purushotham
P. Purushotham
PKP. Kar
P. Kar
PPP. Payal
P. Payal
SSS. Saha
S. Saha
VDV. Deshmukh
V. Deshmukh
Aim of the study was to compare the viral load and clinical status among different age groups with COVID-19 infection A retrospective cross-sectional study was carried out to analyse the Ct values of positive samples reported during April 2020 till May 2021. Result of 13,820 number of RT-PCR positive samples were included for analysis of Ct values. Ct values of confirmatory genes were taken into consideration and Ct values below 25, >25 to 30 and >30 was categorized as high, moderate and low viral load respectively. Age group was stratified into ≤18 years, 18-60 and >60 years as young, adult and elderly respectively. The data was analysed using SPSS windows version 25.0. The Mean Ct value was 27.9, 26, and 26.2 in young, adult and elderly age group respectively. Mean Ct value of young patients were significantly higher as compared to adult and elderly patients (p<0.05). The percentage of high viral load (Ct<25) was found to be significantly higher in adults and elderly (44.6% & 43.7%) as compared to young (32.2%) (p<0.001). Majority of the covid 19 positive cases belonging to <18 years age (75.9%) were asymptomatic as compared to 64.5% and 59.7% in adult and elderly age groups respectively. Present study observed a significantly high proportion of viral load in the adult and elderly population which plays a substantial contribution to SARS CoV-2 transmission, whereas the majority of the young population being asymptomatic play major role as silent transmitters. The study reemphasizes the need for strict adherence to COVID appropriate behaviours.